This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Braunwald E et al. (2002) ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction—summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40: 1366–1374
Schulman SP (2004) Antiplatelet therapy in non-ST-segment elevation acute coronary syndromes. JAMA 292: 1875–1882
Boersma E et al. (2002) Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet 359: 189–198
Kastrati A et al. (2004) A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med 350: 232–238
Antman EM et al. (2000) The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 284: 835–842
Acknowledgements
The synopsis was written by Carol Lovegrove, Freelance Medical Writer.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Keeley, E. Abciximab following clopidogrel reduces post-PCI complications in patients with acute coronary syndromes. Nat Rev Cardiol 3, 650–651 (2006). https://doi.org/10.1038/ncpcardio0706
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpcardio0706